Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Different Issues for Employed and Unemployed Patients With axSpA
02/10/2022
Researchers in Spain found that patients with axial spondyloarthritis face different issues depending on their job status.
Researchers in Spain found that patients with axial spondyloarthritis face different issues depending on their job status.
Researchers in Spain found that...
02/10/2022
Autoimmune
News
Patients With ChildCRD Perform Worse Academically
02/02/2022
A recent study found that, when compared to their unaffected peers, patients with childhood-onset chronic rheumatic diseases performed worse on grade 12 standardized testing.
A recent study found that, when compared to their unaffected peers, patients with childhood-onset chronic rheumatic diseases performed worse on grade 12 standardized testing.
A recent study found that, when...
02/02/2022
Rheumatology & Arthritis

Advertisement

News
C-Reactive Protein Testing is More Widely Used in Europe than the US in the Diagnosis and Monitoring of Psoriatic Arthritis
01/31/2022
In a study published in Rheumatology Therapy, researchers investigated how CRP testing is implemented in real-world clinical practice for disease management of PsA.
In a study published in Rheumatology Therapy, researchers investigated how CRP testing is implemented in real-world clinical practice for disease management of PsA.
In a study published in...
01/31/2022
The Dermatologist
News
Telemedicine Preferred Among Patients With Autoimmune Rheumatic Disease
01/27/2022
A recent study found that patients with autoimmune rheumatic disease were satisfied with video visits and even preferred telemedicine for certain visit reasons.
A recent study found that patients with autoimmune rheumatic disease were satisfied with video visits and even preferred telemedicine for certain visit reasons.
A recent study found that...
01/27/2022
Autoimmune
News
PROMIS On Par With HAQ Disability Index
01/25/2022
For determining minimal disease activity among patients with psoriatic arthritis, researchers found that the Patient-Reported Outcomes Measurement Information System can be a reliable alternative to the Health Assessment Questionnaire...
For determining minimal disease activity among patients with psoriatic arthritis, researchers found that the Patient-Reported Outcomes Measurement Information System can be a reliable alternative to the Health Assessment Questionnaire...
For determining minimal disease...
01/25/2022
Rheumatology & Arthritis

Advertisement

FDA Alerts
FDA Approves Risankizumab-rzaa for Adult Patients With Active Psoriatic Arthritis
01/24/2022
The IL-23 inhibitor has already been approved for the treatment of plaque psoriasis.
The IL-23 inhibitor has already been approved for the treatment of plaque psoriasis.
The IL-23 inhibitor has already...
01/24/2022
The Dermatologist
News
Lifestyle Choices May Reduce Risk of RA
01/21/2022
Analysis of the Nurses’ Health Study reveals that women can influence their risk of developing rheumatoid arthritis through choices in 5 areas.
Analysis of the Nurses’ Health Study reveals that women can influence their risk of developing rheumatoid arthritis through choices in 5 areas.
Analysis of the Nurses’ Health...
01/21/2022
Rheumatology & Arthritis
News
Two Doses of COVID-19 Vaccine Inadequate for Immunosuppressed Patients With AAV
01/20/2022
Immunosuppressed patients with antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis (AAV) receiving rituximab may not achieve adequate response to COVID-19 vaccines even after a third dose, research shows.
Immunosuppressed patients with antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis (AAV) receiving rituximab may not achieve adequate response to COVID-19 vaccines even after a third dose, research shows.
Immunosuppressed patients with...
01/20/2022
Autoimmune

Advertisement

News
Abrocitinib and Upadacitinib Approved for Atopic Dermatitis
01/19/2022
The United States Food and Drug Administration approved Janus kinase 1 (JAK1) inhibitors abrocitinib and upadacitinib for the treatment of adults with refractory, moderate-to-severe atopic dermatitis.
The United States Food and Drug Administration approved Janus kinase 1 (JAK1) inhibitors abrocitinib and upadacitinib for the treatment of adults with refractory, moderate-to-severe atopic dermatitis.
The United States Food and Drug...
01/19/2022
Autoimmune
News
Parallel Studies Identify, Compare Risk Factors for Inflammatory Conditions
01/12/2022
Researchers found some identical and some differing risk factors for developing psoriatic arthritis, psoriasis, rheumatoid arthritis, and ankylosing spondylitis.
Researchers found some identical and some differing risk factors for developing psoriatic arthritis, psoriasis, rheumatoid arthritis, and ankylosing spondylitis.
Researchers found some identical...
01/12/2022
Rheumatology & Arthritis

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Popular Articles

Thomas Werfel, MD, on the Safety of Tralokinumab for the Treatment of Atopic Dermatitis
Q&As
Thomas Werfel, MD, on the Safety of Tralokinumab for the Treatment of Atopic Dermatitis
02/11/2021
In this Q&A, Thomas Werfel, MD, discussed findings from pooled analyses that investigated the safety of tralokinumab among patients with atopic dermatitis.
In this Q&A, Thomas Werfel, MD, discussed findings from pooled analyses that investigated the safety of tralokinumab among patients with atopic dermatitis.
In this Q&A, Thomas Werfel, MD,...
02/11/2021
Autoimmune
News
COVID-19 Vaccine Urged for Patients With Celiac Disease
12/16/2020
The Society for the Study of Celiac Disease is encouraging patients with celiac disease to receive a COVID-19 vaccine that has met government regulatory approval.
The Society for the Study of Celiac Disease is encouraging patients with celiac disease to receive a COVID-19 vaccine that has met government regulatory approval.
The Society for the Study of...
12/16/2020
Autoimmune
News
Statins May Reduce Joint Replacement Risk Among Patients With RA
10/26/2020
Do statins have a potential benefit on disease activity in rheumatoid arthritis? Because the existing evidence is conflicting, researchers evaluated the association.
Do statins have a potential benefit on disease activity in rheumatoid arthritis? Because the existing evidence is conflicting, researchers evaluated the association.
Do statins have a potential...
10/26/2020
Autoimmune
News
Managing IBD With Medical Marijuana: More Evidence Is Needed
09/09/2020
A new meta-analysis shed light on the research that is still needed to support the use of medical marijuana in the management of ulcerative colitis or Crohn disease for induction of remission or response to therapy.
A new meta-analysis shed light on the research that is still needed to support the use of medical marijuana in the management of ulcerative colitis or Crohn disease for induction of remission or response to therapy.
A new meta-analysis shed light...
09/09/2020
Autoimmune
News
Smoking Cessation Reduces RA Disease Activity, Improves Lipid Profiles
07/27/2020
Smoking is a known risk factor in cardiovascular disease and several cancers. But what impact, if any, does smoking have on rheumatoid arthritis? A new study supplies some answers.
Smoking is a known risk factor in cardiovascular disease and several cancers. But what impact, if any, does smoking have on rheumatoid arthritis? A new study supplies some answers.
Smoking is a known risk factor...
07/27/2020
Autoimmune

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Stay In the Know

Autoimmune Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use